A carregar...

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal history of invasive breast cancer is unknown. We identified a cohort of 148 female BRCA1 or BRCA2 mutation carriers (115 and 33, respectively) who previously were treated for un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van Sprundel, T C, Schmidt, M K, Rookus, M A, Brohet, R, van Asperen, C J, Rutgers, E J Th, van‘t Veer, L J, Tollenaar, R A E M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361560/
https://ncbi.nlm.nih.gov/pubmed/16052221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!